Abstract
Cannabis is a potential treatment for epilepsy, although the few human studies supporting this use have proved inconclusive. Previously, we showed that a standardized cannabis extract (SCE), isolated Delta9-tetrahydrocannabinol (Delta9-THC), and even Delta9-THC-free SCE inhibited muscarinic agonist-induced epileptiform bursting in rat olfactory cortical brain slices, acting via CB1 receptors. The present work demonstrates that although Delta9-THC (1 microM) significantly depressed evoked depolarizing postsynaptic potentials (PSPs) in rat olfactory cortex neurones, both SCE and Delta9-THC-free SCE significantly potentiated evoked PSPs (all results were fully reversed by the CB1 receptor antagonist SR141716A, 1 microM); interestingly, the potentiation by Delta9-THC-free SCE was greater than that produced by SCE. On comparing the effects of Delta9-THC-free SCE upon evoked PSPs and artificial PSPs (aPSPs; evoked electrotonically following brief intracellular current injection), PSPs were enhanced, whereas aPSPs were unaffected, suggesting that the effect was not due to changes in background input resistance. Similar recordings made using CB1 receptor-deficient knockout mice (CB1-/-) and wild-type littermate controls revealed cannab...Continue Reading
References
Dec 18, 1992·Science·W A DevaneR Mechoulam
Mar 1, 1980·Journal of Natural Products·C E TurnerE G Boeren
Aug 1, 1981·Journal of Clinical Pharmacology·E A Carlini, J M Cunha
Jan 15, 1999·Science·C LedentM Parmentier
Sep 21, 2000·European Journal of Biochemistry·M D Mark, S Herlitze
Nov 4, 2000·Expert Opinion on Investigational Drugs·R G Pertwee
Nov 25, 2000·Peptides·G Moldrich, T Wenger
Mar 17, 2001·British Journal of Pharmacology·M KathmannE Schlicker
Apr 21, 2001·The Journal of Physiology·C C HuangK S Hsu
Aug 28, 2001·Neuropharmacology·F NavaG L Gessa
Nov 1, 2001·Archives of General Psychiatry·H G PopeD Yurgelun-Todd
Apr 27, 2002·Science·Rachel I Wilson, Roger A Nicoll
May 31, 2002·Pharmacological Reviews·A C HowlettR G Pertwee
Mar 6, 2003·CNS Drugs·J Ludovic Croxford
Aug 13, 2003·The European Journal of Neuroscience·Alexander F HoffmanCarl R Lupica
Oct 2, 2003·Expert Opinion on Investigational Drugs·Sheila A Doggrell, Suzanne Evans
Citations
Mar 30, 2010·Psychopharmacology·Jonathan A FarrimondClaire M Williams
Jun 4, 2005·Pharmacology, Biochemistry, and Behavior·Zuzana JustinovaGianluigi Tanda
Mar 18, 2010·Therapeutics and Clinical Risk Management·Paul F Smith
Oct 24, 2014·Analytical and Bioanalytical Chemistry·Oier Aizpurua-OlaizolaAresatz Usobiaga
Sep 20, 2011·Pharmacology & Therapeutics·Andrew J HillGary J Stephens
May 22, 2008·British Journal of Pharmacology·I DennisG J Stephens
Aug 2, 2013·British Journal of Pharmacology·T D M HillA J Hill
Jan 8, 2011·Phytotherapy Research : PTR·Jonathan A FarrimondClaire M Williams
Sep 26, 2006·Neuroscience Letters·Duncan RyanBettina Platt
Oct 8, 2005·Medical Hypotheses·Ethan Russo, Geoffrey W Guy
Jun 7, 2005·Expert Opinion on Drug Safety·Paul F Smith
Dec 28, 2016·International Journal of Molecular Sciences·Rosaliana LibroOriana Trubiani
Feb 2, 2010·Chemical & Pharmaceutical Bulletin·Justin FischedickRobert Verpoorte
Apr 13, 2012·PloS One·Colleen A PaytonDaniel W Wesson